Viral deletions among healthy young Chinese adults with occult hepatitis B virus infection

Virus Research

Volumn 163, Issue 1, 2012, Pages 197-201

  Chen, Si Jia ^a,b,c   Zhao, Ying Xin ^a,b,c,d   Fang, Yong ^a,b,c   Xu, Wei Zhen ^a,b,c   Ma, Yan Xiu ^a,b,c   Song, Zhi Wei ^a,b,c,d   Teng, Xu ^a,b,c   Gu, Hong Xi ^a,b,c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Heilongjiang Provincial Key Laboratory for Infection and Immunity   (China)

^c Key Lab of Heilongjiang Province Education Bureau for Etiology   (China)

^d THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Deletion; Hepatitis B virus; Occult infection

Indexed keywords

PRIMER DNA; VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CANCER RISK; CHINA; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE DELETION; GENE MUTATION; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SERUM; VACCINATION; VIRUS GENE; VIRUS ISOLATION;

ADOLESCENT; CHINA; CLONING, MOLECULAR; CLUSTER ANALYSIS; DNA PRIMERS; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MALE; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; SERUM; TRANS-ACTIVATORS;

HEPATITIS B VIRUS;

EID: 84855583209     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.09.029     Document Type: Article

References (29)

1. Beck J., Nassal M. Formation of a functional hepatitis B virus replication initiation complex involves a major structural alteration in the RNA template. Mol. Cell. Biol. 1998, 18(11):6265-6272.
2. Blum H.E., Liang T.J., Galun E., Wands J.R. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 1991, 14(1):56-63.
3. Brunetto M.R., Rodriguez U.A., Bonino F. Hepatitis B virus mutants. Intervirology 1999, 42(2-3):69-80.
4. Datta S., Banerjee A., Chandra P.K., Chowdhury A., Chakravarty R. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers. J. Med. Virol. 2006, 78(1):53-59.
5. Ganem D. Assembly of hepadnaviral virions and subviral particles. Curr. Top. Microbiol. Immunol. 1991, 168:61-83.
6. Garcia T., Li J., Sureau C., Ito K., Qin Y., Wands J., Tong S. Drastic reduction in the production of subviral particles does not impair hepatitis B virus virion secretion. J. Virol. 2009, 83(21):11152-11165.
7. Gunther S., Li B.C., Miska S., Kruger D.H., Meisel H., Will H. A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J. Virol. 1995, 69(9):5437-5444.
8. Hahn S., Buratowski S., Sharp P.A., Guarente L. Yeast TATA-binding protein TFIID binds to TATA elements with both consensus and nonconsensus DNA sequences. Proc. Natl. Acad. Sci. U. S. A. 1989, 86(15):5718-5722.
9. Hass M., Hannoun C., Kalinina T., Sommer G., Manegold C., Gunther S. Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals. Hepatology 2005, 42(1):93-103.
10. Hoofnagle J.H., Seeff L.B., Bales Z.B., Zimmerman H.J. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N. Engl. J. Med. 1978, 298(25):1379-1383.
11. Hou J., Karayiannis P., Waters J., Luo K., Liang C., Thomas H.C. A unique insertion in the S gene of surface antigen--negative hepatitis B virus Chinese carriers. Hepatology 1995, 21(2):273-278.
12. Itoh Y., Takai E., Ohnuma H., Kitajima K., Tsuda F., Machida A., Mishiro S., Nakamura T., Miyakawa Y., Mayumi M. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc. Natl. Acad. Sci. U. S. A. 1986, 83(23):9174-9178.
13. Jeantet D., Chemin I., Mandrand B., Zoulim F., Trepo C., Kay A. Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Hepatology 2002, 35(5):1215-1224.
14. Kao C.C., Lieberman P.M., Schmidt M.C., Zhou Q., Pei R., Berk A.J. Cloning of a transcriptionally active human TATA binding factor. Science 1990, 248(4963):1646-1650.
15. Kim Y., Hong Y.B., Jung G. Hepatitis B virus: DNA polymerase activity of deletion mutants. Biochem. Mol. Biol. Int. 1999, 47(2):301-308.
16. Kumar S., Tamura K., Nei M. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief. Bioinform. 2004, 5(2):150-163.
17. Lu F.M., Zhuang H. Management of hepatitis B in China. Chin. Med. J. (Engl.) 2009, 122(1):3-4.
18. Maeng C.Y., Ryu C.J., Gripon P., Guguen-Guillouzo C., Hong H.J. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1. Virology 2000, 270(1):9-16.
19. Milich D.R., Jones J.E., Hughes J.L., Price J., Raney A.K., McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?. Proc. Natl. Acad. Sci. U. S. A. 1990, 87(17):6599-6603.
20. Minuk G.Y., Sun D.F., Uhanova J., Zhang M., Caouette S., Nicolle L.E., Gutkin A., Doucette K., Martin B., Giulivi A. Occult hepatitis B virus infection in a North American community-based population. J. Hepatol. 2005, 42(4):480-485.
21. Mun H.S., Lee S.A., Jee Y., Kim H., Park J.H., Song B.C., Yoon J.H., Kim Y.J., Lee H.S., Hyun J.W., Hwang E.S., Kook Y.H., Kim B.J. The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C. J. Med. Virol. 2008, 80(7):1189-1194.
22. Norder H., Courouce A.M., Magnius L.O. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994, 198(2):489-503.
23. Roossinck M.J., Jameel S., Loukin S.H., Siddiqui A. Expression of hepatitis B viral core region in mammalian cells. Mol. Cell. Biol. 1986, 6(5):1393-1400.
24. Schories M., Peters T., Rasenack J. Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection. J. Hepatol. 2000, 33(5):799-811.
25. Song E.Y., Yun Y.M., Park M.H., Seo D.H. Prevalence of occult hepatitis B virus infection in a general adult population in Korea. Intervirology 2009, 52(2):57-62.
26. Walz A., Wirth S., Hucke J., Gerner P. Vertical transmission of hepatitis B virus (HBV) from mothers negative for HBV surface antigen and positive for antibody to HBV core antigen. J. Infect. Dis. 2009, 200(8):1227-1231.
27. Wands J.R., Chura C.M., Roll F.J., Maddrey W.C. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology 1975, 68(1):105-112.
28. Wobbe C.R., Struhl K. Yeast and human TATA-binding proteins have nearly identical DNA sequence requirements for transcription in vitro. Mol. Cell. Biol. 1990, 10(8):3859-3867.
29. Yin J., Zhang H., He Y., Xie J., Liu S., Chang W., Tan X., Gu C., Lu W., Wang H., Bi S., Cui F., Liang X., Schaefer S., Cao G. Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study. Cancer Epidemiol. Biomarkers Prev. 2010, 19(3):777-786.